Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Market Analysis & Valuation

UpdatedAug 22, 2026
DataAggregated Company Financials
Companies7728
  • 7D-1.5%
  • 3M2.4%
  • 1Y17.9%
  • YTD10.5%

Over the last 7 days, the market has dropped 1.5%, driven by a decline of 3.5% in the Information Technology sector. On the other hand, the Healthcare has risen by 4.1%. In contrast to the last week, the market is actually up 18% over the past year. Looking forward, earnings are forecast to grow by 17% annually.

Trending IndustriesOil and GasGoldBiotechSoftwareRenewable Energy

Market Valuation and Performance

Has the U.S. Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 22 Aug 2026US$76.5tUS$25.1tUS$2.7t19.1x28.1x3x
Mon, 20 Jul 2026US$79.6tUS$24.4tUS$2.5t19.2x31.8x3.3x
Wed, 17 Jun 2026US$76.6tUS$24.3tUS$2.5t19x31.1x3.2x
Fri, 15 May 2026US$73.1tUS$24.2tUS$2.4t18.7x30.2x3x
Sun, 12 Apr 2026US$71.5tUS$23.7tUS$2.3t19.2x31x3x
Tue, 10 Mar 2026US$70.7tUS$23.7tUS$2.3t19x30.8x3x
Thu, 05 Feb 2026US$72.5tUS$23.4tUS$2.3t19.5x31.5x3.1x
Sat, 03 Jan 2026US$71.5tUS$23.2tUS$2.3t19x31.2x3.1x
Mon, 01 Dec 2025US$71.7tUS$23.1tUS$2.3t18.7x31.5x3.1x
Wed, 29 Oct 2025US$72.5tUS$22.8tUS$2.3t18.8x32.2x3.2x
Fri, 26 Sep 2025US$70.2tUS$22.9tUS$2.2t19.1x32.1x3.1x
Sun, 24 Aug 2025US$67.9tUS$23.0tUS$2.2t19.3x31.4x2.9x
Tue, 22 Jul 2025US$65.9tUS$22.5tUS$2.1t18.7x31.3x2.9x
Thu, 19 Jun 2025US$62.5tUS$22.5tUS$2.1t17.7x29.8x2.8x
Sat, 17 May 2025US$61.8tUS$22.5tUS$2.1t18.1x29.5x2.8x
Mon, 14 Apr 2025US$55.3tUS$21.9tUS$2.1t16.3x26.9x2.5x
Wed, 12 Mar 2025US$58.3tUS$21.9tUS$2.0t17.1x28.5x2.7x
Fri, 07 Feb 2025US$64.1tUS$21.8tUS$2.0t18.7x31.6x2.9x
Sun, 05 Jan 2025US$62.5tUS$22.0tUS$1.9t18.4x32.3x2.8x
Tue, 03 Dec 2024US$63.7tUS$22.0tUS$1.9t19.6x33x2.9x
Thu, 31 Oct 2024US$60.5tUS$21.7tUS$1.9t18.2x32.2x2.8x
Sat, 28 Sep 2024US$59.5tUS$21.6tUS$1.9t18.3x31.9x2.8x
Mon, 26 Aug 2024US$58.1tUS$21.5tUS$1.8t18.1x31.5x2.7x
Wed, 24 Jul 2024US$57.8tUS$21.3tUS$1.8t18x31.4x2.7x
Fri, 21 Jun 2024US$56.7tUS$21.3tUS$1.8t16.7x30.9x2.7x
Sun, 19 May 2024US$55.1tUS$21.2tUS$1.8t17.5x30.4x2.6x
Tue, 16 Apr 2024US$53.2tUS$21.1tUS$1.8t16.5x28.8x2.5x
Thu, 14 Mar 2024US$53.8tUS$21.1tUS$1.8t16.6x29.2x2.6x
Sat, 10 Feb 2024US$52.3tUS$21.0tUS$1.8t16.3x29.3x2.5x
Mon, 08 Jan 2024US$49.3tUS$21.0tUS$1.8t16.7x28x2.3x
Wed, 06 Dec 2023US$47.9tUS$21.0tUS$1.8t16x27.3x2.3x
Fri, 03 Nov 2023US$44.3tUS$21.0tUS$1.7t15.2x25.8x2.1x
Sun, 01 Oct 2023US$45.3tUS$21.0tUS$1.7t15.4x26.4x2.2x
Tue, 29 Aug 2023US$46.3tUS$20.9tUS$1.7t15.6x27x2.2x
Price to Earnings Ratio

27x


Total Market Cap: US$46.3tTotal Earnings: US$1.7tTotal Revenue: US$20.9tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Market Price to Earnings3Y Average 30.2x202420252026
Current Market PE
  • Investors are relatively neutral on the American market at the moment, indicating that they expect earnings will grow in line with historical growth rates.
  • The market is trading close to its 3-year average PE ratio of 30.2x.
Past Earnings Growth
  • The earnings for American listed companies have grown 17% per year over the last three years.
  • Revenues for these companies have grown 6.2% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Sector Trends

Which sectors have driven the changes within the U.S. Market?

US Market-1.53%
Materials4.25%
Healthcare4.15%
Energy2.08%
Consumer Discretionary-0.049%
Real Estate-0.18%
Financials-1.24%
Telecom-1.58%
Consumer Staples-1.84%
Tech-3.51%
Utilities-3.62%
Industrials-3.83%
Sector PE
  • Investors favour the Healthcare sector the most for future growth, which is trading close to its 3-year average PE ratio of 65.5x.
    • The market's confidence is likely because analysts are expecting annual earnings growth of 20.4%, which is higher than its past year's earnings growth of 17.4% per year.
  • The Financials sector is the least preferred by investors for future growth, which is trading close to its 3-year average of 17.5x.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 23% over the next 5 years.
  • This is roughly in line with its past earnings growth rate.
  • In contrast, the Energy sector is expected to see its earnings grow by 6.1% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
TSLA TeslaUS$362.866.0%
+US$81.3b		6.7%PE376.5xConsumer Discretionary
LLY Eli LillyUS$1.26k6.4%
+US$67.1b		76.4%PE41.9xHealthcare
AAPL AppleUS$309.351.1%
+US$49.9b		35.8%PE35xTech
MRK MerckUS$152.5512.3%
+US$41.2b		74.6%PE118.6xHealthcare
MRNA ModernaUS$145.13129.2%
+US$32.7b		435.1%PS26xHealthcare
See more

Market Insights

Header cover image
Every new payment app was supposed to kill Visa and Mastercard. Instead, they got bigger. So what does that mean for the payment stocks on your radar?
Continue reading
Picking portfolio winners takes more than hot air

Latest News

META
US$549.90
Meta Platforms
7D
-6.8%
1Y
-27.1%
LLY
US$1,255.40
Eli Lilly
7D
6.4%
1Y
76.4%
Seeking Alpha • 7h

Eli Lilly: Shaking Off Competition From The Dethroned Novo Nordisk

Summary Eli Lilly has strengthened its global obesity drug market dominance, outpacing Novo Nordisk despite intensifying competition and pricing pressures. LLY's US market share has plateaued at 60–61%, but rising total prescriptions and global expansion underpin continued growth prospects. Valuation has compressed to just over 30x forward earnings, reflecting market expectations for growth deceleration and ongoing pricing competition. I maintain a Buy rating on LLY, supported by pipeline optionality, global consumer program expansion, and resilience amid normalization risks. Read the full article on Seeking Alpha
MSFT
US$483.24
Microsoft
7D
-2.5%
1Y
-4.7%
TSLA
US$362.86
Tesla
7D
6.0%
1Y
6.7%
WMT
US$103.70
Walmart
7D
-10.0%
1Y
7.1%
MRK
US$152.55
Merck
7D
12.3%
1Y
74.6%
AAPL
US$309.35
Apple
7D
1.1%
1Y
35.8%
NVDA
US$214.72
NVIDIA
7D
-4.6%
1Y
20.6%
SCCO
US$216.00
Southern Copper
7D
17.0%
1Y
130.2%
ABBV
US$264.96
AbbVie
7D
6.2%
1Y
25.8%
MRNA
US$145.13
Moderna
7D
129.2%
1Y
435.1%
AMZN
US$258.63
Amazon.com
7D
-1.5%
1Y
13.0%
Seeking Alpha • Aug 21

Amazon: Don't Miss Out On The Clearance Sale

Summary Amazon’s shares have underperformed the S&P 500 index in recent months, setting up a very attractive buying opportunity. Its mix of double-digit percentage e-commerce/Ads/subscription net sales growth and accelerating AWS sales/custom silicon net sales bodes well for the future. Amazon concluded Q2 2026 with a net debt balance of $5.9 billion. Shares are priced at a whopping 33% discount to my updated fair value estimate. Amazon could be primed to produce a 54% upside by the end of September 2027 and 28% annual total returns through 2031. Read the full article on Seeking Alpha
AMD
US$473.25
Advanced Micro Devices
7D
-8.0%
1Y
182.1%
AVGO
US$368.45
Broadcom
7D
-6.2%
1Y
25.3%
Seeking Alpha • Aug 20

Broadcom: Marvell Panic Causes A Huge Buying Opportunity

Summary Broadcom Inc. remains a prime beneficiary of the AI boom, with robust profit growth expected for years. The recent selloff following the Marvell-Alphabet deal is seen as an overreaction; the partnership does not threaten AVGO’s position or growth trajectory. AVGO’s valuation is compelling, with downside risk already priced in even under conservative growth assumptions. Even with bearish growth scenarios, AVGO offers attractive annualized returns of 12%+, with potential for much higher upside if consensus is met or exceeded. Read the full article on Seeking Alpha
INTC
US$90.07
Intel
7D
-12.1%
1Y
263.2%
Seeking Alpha • Aug 20

Intel: Why I Am Not Buying The Dip

Summary Intel delivered impressive second-quarter revenue growth of 25% year-over-year alongside strong gross margin expansion and doubled consensus EPS estimates today. Data Center and AI momentum surged 59% annually, benefiting from server CPU demand, higher average selling prices, and 40% margins. Shareholder dilution from pricing 210.5 million new shares, elevated capital expenditures, and ongoing foundry operating losses create near-term fundamental headwinds. Long-term structural catalysts include Intel 14A foundry customer adoption, Tesla partnerships, EMIB advanced packaging scaling, and expanding agentic CPU demand. Extreme valuation multiples compared to semiconductor peers make execution risks asymmetric, warranting a Hold rating until shares pull back significantly. Read the full article on Seeking Alpha
VMRK
US$66.79
Vivmark Residential
7D
1.3%
1Y
-3.7%
New Narrative • Aug 19

Tight Occupancy And High-Yield Development Pipeline Will Support Long-Term Earnings Quality

Catalysts About Vivmark Residential Vivmark Residential develops, owns and operates multifamily rental communities with a focus on large coastal and select expansion markets. What are the underlying business or industry changes driving this perspective?